Zilver PTX Post-Market Study in Japan
Not Applicable
Completed
- Conditions
- Peripheral Arterial Disease (PAD)
- Interventions
- Device: Zilver PTX Drug-Eluting Stent
- Registration Number
- NCT02254837
- Lead Sponsor
- Cook Group Incorporated
- Brief Summary
Japanese post market clinical study of the Zilver PTX device.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 909
Inclusion Criteria
- Symptomatic peripheral arterial disease (PAD) involving the above-the-knee femoropopliteal arteries
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Zilver PTX Zilver PTX Drug-Eluting Stent -
- Primary Outcome Measures
Name Time Method Rate of adverse events 5 years Occurrence of stent fracture 5 years
- Secondary Outcome Measures
Name Time Method